TICKERNOMICS Sign up
Last Update: 2024-03-28 02:10:23
BALCHEM CORP ( BCPC ) https://www.balchem.com
153.42USD
Sector:
Basic Materials
Industry:
Specialty Chemicals
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
BCPC
23.30%
SPY
32.74%
BCPC
21.63%
SPY
92.93%
BCPC
71.57%
SPY
224.41%
BCPC
227.71%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
5061.73
5015.84
0.04
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
46.63
5.49
4.80
3.18
0.25
22.89
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
18.97
32.79
23.76
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.2167
10.19
11.90
0.79
Other Earnings and Cash Flow Stats:
BALCHEM CORP ( BCPC ) Net Income TTM ($MM) is 100.87
BALCHEM CORP ( BCPC ) Operating Income TTM ($MM) is 131.06
BALCHEM CORP ( BCPC ) Owners' Earnings Annual ($MM) is 195.92
BALCHEM CORP ( BCPC ) Current Price to Owners' Earnings ratio is 25.26
BALCHEM CORP ( BCPC ) EBITDA TTM ($MM) is 186.50
BALCHEM CORP ( BCPC ) EBITDA Margin is 23.76%
Capital Allocation:
BALCHEM CORP ( BCPC ) has paid 0.40 dividends per share and bought back 0.138272 million shares in the past 12 months
BALCHEM CORP ( BCPC ) has reduced its debt by 446.082 million USD in the last 12 months
Capital Structure:
BALCHEM CORP ( BCPC ) Interest-bearing Debt ($MM) as of last quarter is 18
BALCHEM CORP ( BCPC ) Annual Working Capital Investments ($MM) are -30
BALCHEM CORP ( BCPC ) Book Value ($MM) as of last quarter is 1053
BALCHEM CORP ( BCPC ) Debt/Capital as of last quarter is 1%
Other Balance Sheet Stats:
BALCHEM CORP ( BCPC ) has 64 million in cash on hand as of last quarter
BALCHEM CORP ( BCPC ) has 148 million of liabilities due within 12 months, and long term debt 380 as of last quarter
BALCHEM CORP ( BCPC ) has 32 common shares outstanding as of last quarter
BALCHEM CORP ( BCPC ) has 0 million USD of preferred stock value
Academic Scores:
BALCHEM CORP ( BCPC ) Altman Z-Score is 7.42 as of last quarter
BALCHEM CORP ( BCPC ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
BALCHEM CORP ( BCPC ) largest shareholder is Bank of New York Mellon Corp owning 301466 shares at 46.25 ($MM) value
William A Backus(an insider) Sold 7000 shares of BALCHEM CORP ( BCPC ) for the amount of $1086330.00 on 2024-02-26
1.01% of BALCHEM CORP ( BCPC ) is held by insiders, and 90.74% is held by institutions
BALCHEM CORP ( BCPC ) went public on 1986-06-03
Other BALCHEM CORP ( BCPC ) financial metrics:
FCF:117.06
Unlevered Free Cash Flow:200.31
EPS:3.30
Operating Margin:18.97
Gross Profit Margin:32.79
Div. Payout Ratio%:11.84
Div. Growth YoY%:-43.89
Equity Return%:10.11
Beta:0.79
Buffet's Owners Earnings:195.92
Price to Owner's Earnings:25.26
About BALCHEM CORP ( BCPC ) :
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.